Literature DB >> 16714379

Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus.

Leonid Gitlin1, Winfried Barchet, Susan Gilfillan, Marina Cella, Bruce Beutler, Richard A Flavell, Michael S Diamond, Marco Colonna.   

Abstract

The innate immune system recognizes viral dsRNA through two distinct pathways; the Toll-like receptor 3 (TLR3) pathway detects dsRNA phagocytosed in endosomes; the helicases retinoic acid-induced protein I (RIG-I) and melanoma differentiation-associated gene-5 (mda-5) detect cytoplasmic dsRNA generated during viral replication. Both RIG-I and mda-5 can bind polyriboinosinic:polyribocytidylic acid (polyI:C), the synthetic analog of viral dsRNA, and mediate type I IFN responses to polyI:C and multiple RNA viruses in vitro. We generated mda-5-deficient mice and showed that mda-5 is the dominant receptor mediating type I IFN secretion in response to polyI:C in vitro and in vivo. Moreover, mda-5-/- mice exhibited a selectively impaired antiviral response to encephalomyocarditis picornavirus, indicating functional specialization of mda-5 in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16714379      PMCID: PMC1464000          DOI: 10.1073/pnas.0603082103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

Review 1.  Innate immune recognition.

Authors:  Charles A Janeway; Ruslan Medzhitov
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

2.  Triggering the interferon antiviral response through an IKK-related pathway.

Authors:  Sonia Sharma; Benjamin R tenOever; Nathalie Grandvaux; Guo-Ping Zhou; Rongtuan Lin; John Hiscott
Journal:  Science       Date:  2003-04-17       Impact factor: 47.728

3.  Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity.

Authors:  Mitsutoshi Yoneyama; Mika Kikuchi; Kanae Matsumoto; Tadaatsu Imaizumi; Makoto Miyagishi; Kazunari Taira; Eileen Foy; Yueh-Ming Loo; Michael Gale; Shizuo Akira; Shin Yonehara; Atsushi Kato; Takashi Fujita
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

4.  Cell type-specific involvement of RIG-I in antiviral response.

Authors:  Hiroki Kato; Shintaro Sato; Mitsutoshi Yoneyama; Masahiro Yamamoto; Satoshi Uematsu; Kosuke Matsui; Tohru Tsujimura; Kiyoshi Takeda; Takashi Fujita; Osamu Takeuchi; Shizuo Akira
Journal:  Immunity       Date:  2005-07       Impact factor: 31.745

5.  mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties.

Authors:  Dong-chul Kang; Rahul V Gopalkrishnan; Qingping Wu; Eckhard Jankowsky; Anna Marie Pyle; Paul B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

6.  Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines.

Authors:  Alexander D Edwards; Sandra S Diebold; Emma M C Slack; Hideyuki Tomizawa; Hiroaki Hemmi; Tsuneyasu Kaisho; Shizuo Akira; Caetano Reis e Sousa
Journal:  Eur J Immunol       Date:  2003-04       Impact factor: 5.532

7.  Overexpression of Helicard, a CARD-containing helicase cleaved during apoptosis, accelerates DNA degradation.

Authors:  Magdalena Kovacsovics; Fabio Martinon; Olivier Micheau; Jean Luc Bodmer; Kay Hofmann; Jürg Tschopp
Journal:  Curr Biol       Date:  2002-05-14       Impact factor: 10.834

8.  Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3.

Authors:  Rashu B Seth; Lijun Sun; Chee-Kwee Ea; Zhijian J Chen
Journal:  Cell       Date:  2005-09-09       Impact factor: 41.582

Review 9.  TLR3 in antiviral immunity: key player or bystander?

Authors:  Martina Schröder; Andrew G Bowie
Journal:  Trends Immunol       Date:  2005-09       Impact factor: 16.687

10.  IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway.

Authors:  Katherine A Fitzgerald; Sarah M McWhirter; Kerrie L Faia; Daniel C Rowe; Eicke Latz; Douglas T Golenbock; Anthony J Coyle; Sha-Mei Liao; Tom Maniatis
Journal:  Nat Immunol       Date:  2003-05       Impact factor: 25.606

View more
  498 in total

1.  Peroxisomes are signaling platforms for antiviral innate immunity.

Authors:  Evelyn Dixit; Steeve Boulant; Yijing Zhang; Amy S Y Lee; Charlotte Odendall; Bennett Shum; Nir Hacohen; Zhijian J Chen; Sean P Whelan; Marc Fransen; Max L Nibert; Giulio Superti-Furga; Jonathan C Kagan
Journal:  Cell       Date:  2010-05-06       Impact factor: 41.582

2.  The toll-like receptor 3-mediated antiviral response is important for protection against poliovirus infection in poliovirus receptor transgenic mice.

Authors:  Yuko Abe; Ken Fujii; Noriyo Nagata; Osamu Takeuchi; Shizuo Akira; Hiroyuki Oshiumi; Misako Matsumoto; Tsukasa Seya; Satoshi Koike
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

3.  Phase I study utilizing a novel antigen-presenting cell-targeted vaccine with Toll-like receptor stimulation to induce immunity to self-antigens in cancer patients.

Authors:  Michael A Morse; Robert Chapman; John Powderly; Kimberly Blackwell; Tibor Keler; Jennifer Green; Renee Riggs; Li-Zhen He; Venky Ramakrishna; Laura Vitale; Biwei Zhao; Stephen A Butler; Amy Hobeika; Takuya Osada; Thomas Davis; Timothy Clay; H Kim Lyerly
Journal:  Clin Cancer Res       Date:  2011-06-01       Impact factor: 12.531

Review 4.  Sensing of RNA viruses: a review of innate immune receptors involved in recognizing RNA virus invasion.

Authors:  Søren Jensen; Allan Randrup Thomsen
Journal:  J Virol       Date:  2012-01-18       Impact factor: 5.103

Review 5.  Pattern recognition of viral nucleic acids by RIG-I-like helicases.

Authors:  Andreas Schmidt; Stefan Endres; Simon Rothenfusser
Journal:  J Mol Med (Berl)       Date:  2010-09-04       Impact factor: 4.599

6.  Toll-like receptor 3-mediated suppression of TRAMP prostate cancer shows the critical role of type I interferons in tumor immune surveillance.

Authors:  Arnold I Chin; Andrea K Miyahira; Anthony Covarrubias; Juli Teague; Beichu Guo; Paul W Dempsey; Genhong Cheng
Journal:  Cancer Res       Date:  2010-03-16       Impact factor: 12.701

7.  Induction and inhibition of type I interferon responses by distinct components of lymphocytic choriomeningitis virus.

Authors:  Shenghua Zhou; Anna M Cerny; An Zacharia; Katherine A Fitzgerald; Evelyn A Kurt-Jones; Robert W Finberg
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

8.  Different strains of Theiler's murine encephalomyelitis virus antagonize different sites in the type I interferon pathway.

Authors:  Spyridon Stavrou; Zongdi Feng; Stanley M Lemon; Raymond P Roos
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

Review 9.  Innate antiviral immune signaling, viral evasion and modulation by HIV-1.

Authors:  Arjun Rustagi; Michael Gale
Journal:  J Mol Biol       Date:  2013-12-08       Impact factor: 5.469

10.  Regulation of TLR3 Activation by S100A9.

Authors:  Su-Yu Tsai; Jesus A Segovia; Te-Hung Chang; Niraj K Shil; Swechha M Pokharel; T R Kannan; Joel B Baseman; Joan Defrêne; Nathalie Pagé; Annabelle Cesaro; Philippe A Tessier; Santanu Bose
Journal:  J Immunol       Date:  2015-09-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.